{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:36:47Z","timestamp":1791247007183,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41409-025-02735-7","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:05:56Z","timestamp":1762329956000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT"],"prefix":"10.1038","volume":"61","author":[{"given":"Vanderson","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-4748","authenticated-orcid":false,"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Raiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-8310","authenticated-orcid":false,"given":"Raynier","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-0123","authenticated-orcid":false,"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luiz","family":"Diez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yener","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-1976","authenticated-orcid":false,"given":"Johanna","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2426-3465","authenticated-orcid":false,"given":"Simona","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-808X","authenticated-orcid":false,"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"G\u00fclbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-4136","authenticated-orcid":false,"given":"Aleksandr","family":"Kulagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-5596","authenticated-orcid":false,"given":"Luc\u00eda L\u00f3pez","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9102-4427","authenticated-orcid":false,"given":"Jacques Emmanuel","family":"Galimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-6970","authenticated-orcid":false,"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-2765","authenticated-orcid":false,"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"from the Cellular Therapy & Immunobiology Working Party of the European Society for Blood and Marrow Transplantation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2735_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, post-transplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2735_CR2","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbmt.2019.07.028","volume":"25","author":"LJ Arcuri","year":"2019","unstructured":"Arcuri LJ, Aguiar MTM, Ribeiro AAF, Pacheco AGF, Kerbauy MN, Bonfim CM. Haploidentical transplantation with post-transplant cyclophosphamide versus unrelated donor hematopoietic stem cell transplantation: a systematic review and meta-analysis. Biol Blood Marrow Transpl. 2019;25:2422\u201330.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2735_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41409-022-01577-x","volume":"57","author":"G Battipaglia","year":"2022","unstructured":"Battipaglia G, Galimard JE, Labopin M, Raiola AM, Blaise D, Ruggeri A, et al. Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT. Bone Marrow Transpl. 2022;57:562\u201371. https:\/\/doi.org\/10.1038\/s41409-022-01577-x.","journal-title":"Bone Marrow Transpl"},{"key":"2735_CR4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012;367:1487\u201396.","journal-title":"N Engl J Med"},{"key":"2735_CR5","doi-asserted-by":"publisher","first-page":"782.e1","DOI":"10.1016\/j.jtct.2021.06.011","volume":"27","author":"LJ Arcuri","year":"2021","unstructured":"Arcuri LJ, Hamerschlak N, Rocha V, Bonfim C, Kerbauy MN, Ribeiro AAF. Outcomes after haploidentical hematopoietic cell transplantation with post transplantation cyclophosphamide: a systematic review and meta-analysis comparing myeloablative with reduced-intensity conditioning regimens and bone marrow with peripheral blood stem cell grafts. Transplantation Cell Ther. 2021;27:782.e1\u2013782.e7.","journal-title":"Transplantation Cell Ther"},{"key":"2735_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bmt.2015.305","volume":"51","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Labopin M, Ciceri F, Mohty M, Nagler A. Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission. Bone Marrow Transpl. 2016;51:610\u20131.","journal-title":"Bone Marrow Transpl"},{"key":"2735_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bmt.1701899","volume":"24","author":"R Martino","year":"1999","unstructured":"Martino R, Romero P, Subir\u00e1 M, Sureda A, Brunet S, Urbano-Ispizua A, et al. Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. Bone Marrow Transpl. 1999;24:283\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"2735_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transpl. 2015;21:389\u2013401.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2735_CR9","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#","volume":"18","author":"PK Andersen","year":"1999","unstructured":"Hougaard P. Frailty models for survival data. Lifetime Data Anal 1995;1:255\u201373, Andersen PK, Klein JP, Zhang MJ. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med. 1999;18:1489\u2013500.","journal-title":"Stat Med"},{"key":"2735_CR10","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","volume":"98","author":"M Korbling","year":"2001","unstructured":"Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood. 2001;98:2900\u20138.","journal-title":"Blood"},{"key":"2735_CR11","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"SR Solomon","year":"2012","unstructured":"Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, et al. Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial. Biol Blood Marrow Transpl. 2012;18:1859\u201366.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2735_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6950346","volume":"2016","author":"S Farhan","year":"2016","unstructured":"Farhan S, Peres E, Janakiraman N, Jagasia M, Bashey A, Solomon SR. Choice of unmanipulated T cell replete graft for haploidentical stem cell transplant and posttransplant cyclophosphamide in hematologic malignancies in adults: peripheral blood or bone marrow\u2014review of published literature. Adv Hematol. 2016;2016:6950346.","journal-title":"Adv Hematol"},{"key":"2735_CR13","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1200\/JCO.2017.73.7775","volume":"35","author":"SM Devine","year":"2017","unstructured":"Devine SM. Haploidentical hematopoietic cell transplantation using post-transplantation cyclophosphamide: does graft source matter?. J Clin Oncol. 2017;35:2984\u20136.","journal-title":"J Clin Oncol"},{"key":"2735_CR14","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","volume":"35","author":"A Bashey","year":"2017","unstructured":"Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, et al. Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete haploidentical donor transplantation using post-transplant cyclophosphamide. J Clin Oncol. 2017;35:3002\u20139.","journal-title":"J Clin Oncol"},{"key":"2735_CR15","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/cncr.31228","volume":"124","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, G\u00fclbas Z, Koc Y, Blaise D, et al. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. Cancer. 2018;124:1428\u201337.","journal-title":"Cancer"},{"key":"2735_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.bbmt.2020.05.001","volume":"26","author":"A Im","year":"2020","unstructured":"Im A, Rashidi A, Wang T, Hemmer M, MacMillan ML, Pidala J, et al. Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide. Biol Blood Marrow Transpl. 2020;26:1459\u201368.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2735_CR17","doi-asserted-by":"publisher","first-page":"587.e1","DOI":"10.1016\/j.jtct.2022.06.006","volume":"28","author":"G Battipaglia","year":"2022","unstructured":"Battipaglia G, Labopin M, Blaise D, Diez-Martin JL, Bazarbachi A, Vitek A, et al. Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone in acute myelogenous leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Transplant Cell Ther. 2022;28:587.e1\u2013587.e7. https:\/\/doi.org\/10.1016\/j.jtct.2022.06.006.","journal-title":"Transplant Cell Ther"},{"key":"2735_CR18","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00044-7","volume":"2","author":"R Admiraal","year":"2015","unstructured":"Admiraal R, Nierkens S, de Witte MA, Bierings MB, van Kesteren C, Versluijs AB, et al. Association between anti-thymocyte globulin exposure and survival outcomes in pediatric unrelated hematopoietic cell transplantation. Lancet Haematol. 2015;2:e194\u2013203. https:\/\/doi.org\/10.1016\/S2352-3026(15)00044-7.","journal-title":"Lancet Haematol"},{"key":"2735_CR19","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1200\/JCO.2017.73.6352","volume":"35","author":"R Admiraal","year":"2017","unstructured":"Admiraal R, van Kesteren C, Jol-van der Zijde CM, Lankester AC, Bierings MB, Egeler RM, et al. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated hematopoietic cell transplantation. J Clin Oncol. 2017;35:4003\u201312. https:\/\/doi.org\/10.1200\/JCO.2017.73.6352.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02735-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02735-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02735-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:39:04Z","timestamp":1768927144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02735-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02735-7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Data were collected according to EBMT rules. All patients or their legal guardians provided written informed consent for data collection and analysis in accordance with the Declaration of Helsinki, and with the centers\u2019 ethical research guidelines. The scientific board of the CTIWP of the EBMT approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}